Schwann Cell Activity in the Multiple Sclerosis Microenvironment
Cells · 2026
DOI: 10.3390/cells15171570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Michael R Shurin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Schwann Cells, Cellular Microenvironment. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Department of Pathology Internal Path-Grant.
Abstract (Originalsprache)
Schwann cell (SC)-based therapy is currently being debated as an approach to promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS). The main limitation of SC transplantation in MS patients is the short-term functional activity of SCs in the CNS environment. The goal of this study was to determine phenotypic, functional, and signaling changes in human SCs treated with CSF samples from MS patients in vitro, and to characterize the molecular mechanisms underlying SC injury response in the model MS microenvironment. We demonstrated that SC proliferation and motility were suppressed, while the expression of both pro-myelinating genes and negative regulators of myelination was up-regulated in cells incubated with CSF from MS patients. This was associated with active phosphorylation of ERK and c-Jun, and inhibition of these signaling pathways prevented SC changes. The overall analysis of detected abnormalities and SC markers indicates that SCs do not exhibit either a ‘classic’ dedifferentiation-repair-like phenotype or a myelin-forming maturation phenotype when placed in MS-like conditions. They demonstrate an uncommon pattern of cellular signaling reprogramming, associated with decreased motility and potentially decreased myelination. We thus suggest that ERK- and JNK-modulated SCs should be further investigated as a potential cell source for CNS repair in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pathology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
- Departments of Immunology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
- Hillman Cancer Center, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
- Departments of Medicine, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
ORCID-Profile: Michael R Shurin, Galina V Shurin, Anna E Lokshin
Förderung
- NIAID NIH HHS
- Department of Pathology Internal Path-Grant
Zitieren
APA
Shurin, M. R., Shurin, G. V., Doyle, C. M., Lokshin, A. E., & Wheeler, S. E. (2026). Schwann Cell Activity in the Multiple Sclerosis Microenvironment. Cells. https://doi.org/10.3390/cells15171570
Vancouver
Shurin MR, Shurin GV, Doyle CM, Lokshin AE, Wheeler SE. Schwann Cell Activity in the Multiple Sclerosis Microenvironment. Cells. 2026. doi:10.3390/cells15171570
BibTeX
@article{Shurin2026,
author = {Shurin, Michael R and Shurin, Galina V and Doyle, Carolina Moreira and Lokshin, Anna E and Wheeler, Sarah E},
title = {Schwann Cell Activity in the Multiple Sclerosis Microenvironment},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15171570}
}
EUVIMED